Top Industry News
- SWISS New regulations applicable to in vitro diagnostic medical devices as of 26 May 2022
- ANVISA changes import licensing petition migration schedule
- EMA guidance supports development of new antibiotics
- SFDA Requirements for Clinical Trials of Medical Devices (MDS-REQ 2)
- EMEA MDCG shares guidance on the interface of clinical trial and diagnostic regulations
- SFDA Guidelines for Variation Requirements
- Pakistan's DRAP posts draft guidelines on categorizing GMP deficiencies for consultation
- SFDA’s Product Specific Bioequivalence Guidance
- TGA Prescription medicines: registration of new generic medicines and biosimilar medicines
- SWISS Performance studies with IVD